Compston, Alastair.
Antibody therapy of multiple sclerosis [electronic resource] / Alastair Compston & Alasdair Coles. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (48 min.) : color, sound). - Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: The story of multiple sclerosis -- Symptoms -- Pathogenesis -- Pathological heterogeneity -- Axonal degeneration -- Current treatments -- Interferons and glatiramer -- Monoclonal antibody treatment of multiple sclerosis -- Daclizumab -- Natalizumab -- The story of Campath-1H -- The effect of Campath-1H on disability depends upon the stage of the disease -- Graves' disease -- Immune thrombocytopenia -- Future treatment of multiple sclerosis.
Access restricted to subscribers.
Mode of access: World Wide Web.
1264 Henry Stewart Talks
Antibodies, Monoclonal--therapeutic use.
Multiple Sclerosis--therapy.
Multiple Sclerosis.
Antibody therapy of multiple sclerosis [electronic resource] / Alastair Compston & Alasdair Coles. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (48 min.) : color, sound). - Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: The story of multiple sclerosis -- Symptoms -- Pathogenesis -- Pathological heterogeneity -- Axonal degeneration -- Current treatments -- Interferons and glatiramer -- Monoclonal antibody treatment of multiple sclerosis -- Daclizumab -- Natalizumab -- The story of Campath-1H -- The effect of Campath-1H on disability depends upon the stage of the disease -- Graves' disease -- Immune thrombocytopenia -- Future treatment of multiple sclerosis.
Access restricted to subscribers.
Mode of access: World Wide Web.
1264 Henry Stewart Talks
Antibodies, Monoclonal--therapeutic use.
Multiple Sclerosis--therapy.
Multiple Sclerosis.